ZEIDMAN FRED S has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $25K.

Fred S. Zeidman is an American business executive and corporate director. Based on the SEC filing context dated May 18, 2026, he is listed as a director of Bluejay Diagnostics, Inc. The filing confirms his role on Bluejay Diagnostics' board; additional biographical details (education, career history, other board roles) are not provided in the context available here.
| Role | Director |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | BJDX | Bluejay Diagnostics, Inc. | P — Open-market purchase | 12.5K | $2.00 | $25K |
Fred S. Zeidman is an American business executive and corporate director. Based on the SEC filing context dated May 18, 2026, he is listed as a director of Bluejay Diagnostics, Inc. The filing confirms his role on Bluejay Diagnostics' board; additional biographical details (education, career history, other board roles) are not provided in the context available here.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($25K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ZEIDMAN FRED S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.